| Clinical and economic challenges facing pharmacogenomics J Cohen, A Wilson, K Manzolillo The pharmacogenomics journal 13 (4), 378-388, 2013 | 84 | 2013 |
| Development of and access to products for neglected diseases J Cohen, MS Dibner, A Wilson PLoS One 5 (5), e10610, 2010 | 66 | 2010 |
| Off-label use reimbursement J Cohen, A Wilson, L Faden Food & Drug LJ 64, 391, 2009 | 49 | 2009 |
| Patient access to new cancer drugs in the United States and Australia A Wilson, J Cohen Value in Health 14 (6), 944-952, 2011 | 45 | 2011 |
| New challenges to medicare beneficiary access to mAbs J Cohen, A Wilson MAbs 1 (1), 56, 2009 | 20 | 2009 |
| Comparison of Prescription Drug Costs in the U nited S tates and the U nited K ingdom, Part 1: Statins H Jick, A Wilson, P Wiggins, DP Chamberlin Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 32 (1), 1-6, 2012 | 19 | 2012 |
| FDA's Risk Evaluation and Mitigation Strategies (REMS): Effective and Efficient Safety Tools or Process Poltergeist A Wilson, CP Milne Food & Drug LJ 66, 569, 2011 | 19 | 2011 |
| The cost-effectiveness of biopharmaceuticals: A look at the evidence. AW Wilson, PJ Neumann mAbs 4 (2), 2012 | 17 | 2012 |
| Opioid prescription patterns among patients who doctor shop; Implications for providers T Schneberk, B Raffetto, J Friedman, A Wilson, D Kim, DL Schriger Plos one 15 (5), e0232533, 2020 | 16 | 2020 |
| Comparison of Prescription Drug Costs in the U nited S tates and the U nited K ingdom, Part 2: Proton Pump Inhibitors H Jick, A Wilson, P Wiggins, DP Chamberlain Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 32 (6 …, 2012 | 11 | 2012 |
| Comparison of Prescription Drug Costs in the U nited S tates and the U nited K ingdom, Part 3: Methylphenidate H Jick, A Wilson, P Wiggins, DP Chamberlin Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 32 (11 …, 2012 | 6 | 2012 |
| Mathematics for analysis of petascale data P Kegelmeyer, R Calderbank, T Critchlow, L Jameson, C Kamath, J Meza, ... Report on a Department of Energy Workshop, 2008 | 5 | 2008 |
| The cost of prescription drugs: a comparison of two countries H Jick, A Wilson Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 32 (11 …, 2012 | 4 | 2012 |
| Statins: Review of safety and potential side effects S Ramkumar, A Wilson Heart, Lung and Circulation 24, S190, 2015 | 2 | 2015 |
| Comparison of prescription drug costs in the United States and the United Kingdom, Part 4: antibiotics in young children H Jick, A Wilson, D Chamberlin Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 34 (4 …, 2014 | 2 | 2014 |
| Assessing Change in Preservice Teachers’ Beliefs about Learning and Teaching Mathematics A Wilson Society for Information Technology & Teacher Education International …, 2006 | 2 | 2006 |
| PCSK9 inhibitors, the most significant advance in lipid lowering therapy since statins? a literature review A Wilson Osteopathic Family Physician 11 (4), 2019 | 1 | 2019 |
| System and method for creation of evidence-informed case rate budgets for bundled payments M Moses, W Mcguire, Q Coldiron, S Burstein, E Bailey, A Wilson, ... US Patent App. 15/239,604, 2017 | 1 | 2017 |
| Knowledge, beliefs, practices, blood pressure and blood glucose control in women with diabetes mellitus A Wilson, EMW Duff, EY Bailey, R Wright Pascoe West Indian med. j, 36-36, 2001 | 1 | 2001 |
| Real World Validation of Payer Pricing Files: Policy Implications A Wilson, F de Brantes Health Affairs Forefront, 2023 | | 2023 |
